Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

STRO · Insider trading · 13F holders · Congress trades

Sutro Biopharma, Inc. (STRO)

Who is buying and selling STRO: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
13
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

STRO at a glance

  • No open-market insider purchases or sales of STRO were filed in the last 90 days.
  • 13 13F filers hold STRO among their 50 largest positions, worth $249.3M combined, including Joseph Edelman. The biggest bets by portfolio weight are Velan Capital Investment Management LP (10.4%), Acuta Capital Partners, LLC (6.3%) and KVP Capital Advisors, LP (5.5%). In their latest 13Fs, 2 managers opened a new position and 1 added to one.
  • No member of Congress has disclosed a trade in STRO.

STRO insider trading

No open-market insider purchases or sales of STRO were filed in the last 90 days.

Who owns STRO? Hedge funds and superinvestors

13 13F filers hold STRO among their 50 largest positions, worth $249.3M combined, including Joseph Edelman. The biggest bets by portfolio weight are Velan Capital Investment Management LP (10.4%), Acuta Capital Partners, LLC (6.3%) and KVP Capital Advisors, LP (5.5%). In their latest 13Fs, 2 managers opened a new position and 1 added to one.

Superinvestors holding STRO: Joseph Edelman 0.7%

13F filers holding STRO
Manager% of portfolioValueSharesLast quarter13F
Joseph EdelmanHedge fund0.7%$43.3M1,304,846—Q2 2026
Bvf Inc/ilInvestment manager1.1%$41.6M1,251,788+0.0% sharesQ2 2026
Affinity Asset Advisors, LLCHedge fund1.9%$38.9M1,172,487+9.6% sharesQ2 2026
Samsara Biocapital, LLCHedge fund2.9%$35.3M1,062,872+0.0% sharesQ2 2026
Kynam Capital Management, LPHedge fund1.6%$29.0M872,558+0.0% sharesQ2 2026
Velan Capital Investment Management LPHedge fund10.4%$17.0M512,160+0.0% sharesQ2 2026
ADAR1 Capital Management, LLCHedge fund0.6%$13.4M404,014-23.0% sharesQ2 2026
Merck & Co., Inc.Corporation1.7%$9.0M272,351NewQ2 2026
Acuta Capital Partners, LLCHedge fund6.3%$9.0M270,251+0.3% sharesQ2 2026
KVP Capital Advisors, LPHedge fund5.5%$7.5M226,575+0.0% sharesQ2 2026
Seven Fleet Capital Management LPHedge fund0.6%$3.8M159,118—Q2 2026
Elmind Capital, LPHedge fund0.3%$1.1M32,037NewQ2 2026
AJU IB Investment Co., Ltd.Investment manager1.4%$436K17,500+0.0% sharesQ1 2026

Each manager counts with its latest 13F (Q2 2026: 12, Q1 2026: 1). Screen STRO in the grand portfolio →

STRO stock trades by members of Congress

No member of Congress has disclosed a trade in STRO.

STRO questions and answers

Are insiders buying STRO stock?

No open-market insider purchases or sales of STRO were filed in the last 90 days.

Which hedge funds own STRO?

13 13F filers hold STRO among their 50 largest positions, worth $249.3M combined, including Joseph Edelman. The biggest bets by portfolio weight are Velan Capital Investment Management LP (10.4%), Acuta Capital Partners, LLC (6.3%) and KVP Capital Advisors, LP (5.5%). In their latest 13Fs, 2 managers opened a new position and 1 added to one.

Has Congress traded STRO?

No member of Congress has disclosed a trade in STRO.

Who is the largest holder of STRO?

Among 13F filers, Joseph Edelman reports the largest STRO position, $43.3M (1,304,846 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Velan Capital Investment Management LP's: 10.4% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link